Key facts
- Arda Biomaterials’s last known valuation is $14.7M (Mar 2025).
- It has raised $6.7M; the latest was Accelerator/Incubator ($5.2M) in Sep 2025.
- Notable investors include Plug and Play Tech Center, Innovate UK, Creative Destruction Lab, Entrepreneurs First, Tech Nation Group — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Arda Biomaterials
- ·The full record, as it builds
Funding rounds
No funding rounds for Arda Biomaterials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arda Biomaterials
Developer of sustainable biomaterials designed for reducing reliance on animal products and petrochemicals. The company upgrades plant-based proteins from brewery and distillery byproducts into performance materials using proprietary supramolecular chemistry, enabling industries to access versatile, leather-like alternatives that support scalability, sustainability, and the circular economy while minimizing environmental impact.
- Sector
- Materials and Resources
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 20
- Website
- arda.bio/
- Ownership
- Privately Held (backing)
Arda Biomaterials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arda Biomaterials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arda Biomaterials in its N-PORT filings yet. We sweep new filings monthly.